NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.41
-0.61 (-3.81%)
Nov 16, 2026, 4:00 PM EST - Market closed

NeoGenomics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
139.28159.62367.01342.49263.18316.83
Short-Term Investments
--19.8372.72174.81198.56
Cash & Short-Term Investments
139.28159.62386.84415.2437.99515.39
Cash Growth
-15.13%-58.74%-6.83%-5.20%-15.02%73.97%
Receivables
213.41159.24150.64131.26121.61113.87
Inventory
25.528.5726.7524.1624.2823.4
Prepaid Expenses
22.7721.4420.1717.9915.2412.35
Other Current Assets
9.127.4211.628.26.1816.5
Total Current Assets
410.08376.29596.02596.81605.29681.51
Property, Plant & Equipment
170.21163.28173.69183.78198.61211.66
Goodwill
524524.34522.77522.77522.77527.12
Other Intangible Assets
263.63286.53339.68373.13408.26442.33
Long-Term Accounts Receivable
----0.030.24
Long-Term Deferred Charges
0.170.040.010.050.720.88
Other Long-Term Assets
8.839.365.884.694.366.05
Total Assets
1,3771,3601,6381,6811,7401,870

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
32.9323.0921.6120.3320.5117.92
Accrued Expenses
76.9859.5875.0768.2355.2153.1
Current Portion of Long-Term Debt
--200.78-0.071.14
Current Portion of Leases
64.783.385.616.586.88
Current Unearned Revenue
0.270.850.412.137.565.19
Other Current Liabilities
-----3
Total Current Liabilities
116.1788.3301.2496.389.9387.23
Long-Term Debt
374.69341.86340.34538.2535.32532.48
Long-Term Leases
68.4562.8260.8467.8768.9572.29
Long-Term Unearned Revenue
0.360.390.34-0.020.92
Long-Term Deferred Tax Liabilities
16.118.2221.5124.2934.7555.48
Other Long-Term Liabilities
0.5111.6811.4413.0313.0413.11
Total Liabilities
576.28523.27735.7739.69742.01761.5

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.130.130.130.130.130.12
Additional Paid-In Capital
1,2821,2701,2281,1901,1611,124
Retained Earnings
-456.22-433.81-325.78-247.06-159.09-14.84
Comprehensive Income & Other
00-0.21-1.67-3.9-0.64
Total Common Equity
800.64836.56902.34941.54998.021,108
Shareholders' Equity
800.64836.56902.34941.54998.021,108
Total Liabilities & Equity
1,3771,3601,6381,6811,7401,870

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
449.14409.46605.33611.68610.93612.79
Net Cash (Debt)
-309.86-249.84-218.49-196.48-172.94-97.4
Net Cash Growth
------
Net Cash Per Share
-2.40-1.95-1.73-1.57-1.39-0.81
Filing Date Shares Outstanding
129.39129.81128.46127.61127.46124.03
Total Common Shares Outstanding
129.1128.99128.15127.37126.91124.11
Working Capital
293.91287.99294.78500.51515.36594.28
Book Value Per Share
6.206.497.047.397.868.93
Tangible Book Value
13.0225.6939.8945.6467138.84
Tangible Book Value Per Share
0.100.200.310.360.531.12
Machinery
-148.05147.43142.03136.88127.95
Construction In Progress
-7.738.513.618.9812.4
Leasehold Improvements
-59.4157.5749.2344.4243.25
SEC Filings: 10-K · 10-Q